Measuring Neuromuscular Junction Functionality.

Neuromuscular junction (NMJ) functionality plays a pivotal role when studying diseases in which the communication between motor neuron and muscle is impaired, such as aging and amyotrophic lateral sclerosis (ALS). Here we describe an experimental protocol that can be used to measure NMJ functionality by combining two types of electrical stimulation: direct muscle membrane stimulation and the stimulation through the nerve. The comparison of the muscle response to these two different stimulations can help to define, at the functional level, potential alterations in the NMJ that lead to functional decline in muscle. Ex vivo preparations are suited to well-controlled studies. Here we describe an intensive protocol to measure several parameters of muscle and NMJ functionality for the soleus-sciatic nerve preparation and for the diaphragm-phrenic nerve preparation. The protocol lasts approximately 60 min and is conducted uninterruptedly by means of a custom-made software that measures the twitch kinetics properties, the force-frequency relationship for both muscle and nerve stimulations, and two parameters specific to NMJ functionality, i.e. neurotransmission failure and intratetanic fatigue. This methodology was used to detect damages in soleus and diaphragm muscle-nerve preparations by using SOD1G93A transgenic mouse, an experimental model of ALS that ubiquitously overexpresses the mutant antioxidant enzyme superoxide dismutase 1 (SOD1).

[1]  J. Faulkner,et al.  Contractile properties of skeletal muscles from young, adult and aged mice. , 1988, The Journal of physiology.

[2]  Rüdiger Rudolf,et al.  Role of Myosin Va in the Plasticity of the Vertebrate Neuromuscular Junction In Vivo , 2008, PloS one.

[3]  B. Hochner,et al.  Chronic acetylcholinesterase overexpression induces multilevelled aberrations in mouse neuromuscular physiology , 2003, The Journal of physiology.

[4]  S. Bartling,et al.  A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions. , 2008, Human molecular genetics.

[5]  A. Musarò,et al.  Measuring Mechanical Properties, Including Isotonic Fatigue, of Fast and Slow MLC/mIgf-1 Transgenic Skeletal Muscle , 2008, Annals of Biomedical Engineering.

[6]  Young Il Lee,et al.  Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons. , 2011, Developmental biology.

[7]  K. Personius,et al.  Variability and failure of neurotransmission in the diaphragm of mdx mice , 2006, Neuromuscular Disorders.

[8]  J. Faulkner,et al.  Force and power output of fast and slow skeletal muscles from mdx mice 6‐28 months old , 2001, The Journal of physiology.

[9]  C. Mantilla,et al.  Structure–activity relationships in rodent diaphragm muscle fibers vs. neuromuscular junctions , 2012, Respiratory Physiology & Neurobiology.

[10]  E. Melamed,et al.  The “Dying-Back” Phenomenon of Motor Neurons in ALS , 2011, Journal of Molecular Neuroscience.

[11]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[12]  Michelle Moyer,et al.  Adverse effects of myasthenia gravis on rat phrenic diaphragm contractile performance. , 2004, Journal of applied physiology.

[13]  H. Miyata,et al.  Inactivity‐induced remodeling of neuromuscular junctions in rat diaphragmatic muscle , 1999, Muscle & nerve.

[14]  S. Frigo,et al.  1985 , 1985, Literatur in der SBZ/DDR.

[15]  C. Mantilla,et al.  Neurotrophins improve neuromuscular transmission in the adult rat diaphragm , 2004, Muscle & nerve.

[16]  Emanuele Rizzuto,et al.  Measuring Neuromuscular Junction Functionality in the SOD1G93A Animal Model of Amyotrophic Lateral Sclerosis , 2015, Annals of Biomedical Engineering.

[17]  R. Shadmehr,et al.  Relative contribution of neurotransmission failure to diaphragm fatigue. , 1990, Journal of applied physiology.

[18]  A. Musarò,et al.  Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. , 2008, Cell metabolism.

[19]  E. van Lunteren,et al.  Effects of DAP on diaphragm force and fatigue, including fatigue due to neurotransmission failure. , 1996, Journal of applied physiology.

[20]  J. Faulkner,et al.  Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment , 2001, Neuromuscular Disorders.